Twenty signaling pathways were enriched with the criteria of 2 fold changes (Table 4), which include the inositol phosphate metabolism, T cell receptor signaling pathway, phosphatidylinositol signaling system, mTOR signaling pathway, primary immunodeficiency and some cancer signaling pathway. The gene discussed is MTOR; the disease is cancer.